APPLIED DNA SCIENCES INC's ticker is and the CUSIP is 03815U300. A total of 30 filers reported holding APPLIED DNA SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,533 | -6.0% | 2,920 | +0.2% | 0.00% | – |
| Q2 2023 | $3,758 | +14.3% | 2,913 | +0.1% | 0.00% | – |
| Q1 2023 | $3,288 | -31.9% | 2,909 | +0.0% | 0.00% | – |
| Q4 2022 | $4,827 | +60.9% | 2,908 | +0.1% | 0.00% | – |
| Q3 2022 | $3,000 | -57.1% | 2,906 | -68.0% | 0.00% | – |
| Q2 2022 | $7,000 | -68.2% | 9,075 | -14.6% | 0.00% | – |
| Q1 2022 | $22,000 | -50.0% | 10,621 | -3.7% | 0.00% | – |
| Q4 2021 | $44,000 | -24.1% | 11,027 | +3.7% | 0.00% | – |
| Q3 2021 | $58,000 | -14.7% | 10,634 | +5.8% | 0.00% | – |
| Q2 2021 | $68,000 | +9.7% | 10,049 | +17.5% | 0.00% | – |
| Q1 2021 | $62,000 | +72.2% | 8,553 | +24.0% | 0.00% | – |
| Q4 2020 | $36,000 | -32.1% | 6,896 | 0.0% | 0.00% | – |
| Q3 2020 | $53,000 | +960.0% | 6,896 | +986.0% | 0.00% | – |
| Q2 2020 | $5,000 | – | 635 | +420.5% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 122 | -95.7% | 0.00% | – |
| Q4 2019 | $11,000 | – | 2,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 751,780 | $849,511 | 0.12% |
| SABBY MANAGEMENT, LLC | 73,553 | $83,115 | 0.07% |
| Cowen Prime Advisors LLC | 98,301 | $95 | 0.04% |
| Atria Wealth Solutions, Inc. | 81,210 | $91,767 | 0.00% |
| Advisory Services Network, LLC | 1 | $1 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 50,892 | $57,508 | 0.00% |
| UBS Group AG | 12,188 | $13,772 | 0.00% |
| NewEdge Advisors, LLC | 2 | $2 | 0.00% |
| Moisand Fitzgerald Tamayo, LLC | 2,000 | $2,260 | 0.00% |
| OSAIC HOLDINGS, INC. | 2 | $2 | 0.00% |